Empire Post Media, Inc. (EMPM) Spammed Aggressively
We have observed emails spamming Empire Post Media. Investors should be wary of these emails, as they are completely anonymous…
Blog
Last Intermediate Review Completed for Celsion Corp. (CLSN) Phase III HEAT Study of ThermoDox for Treating Primary Liver Cancer
Leading oncology drug development company Celsion Corporation has announced that the independent Data Monitoring Committee (DMC) for its HEAT Study…
Buildablock Corp. (BABL) Schedules Beta Launch of Website and Mobile App
Internet service platform company Buildablock today announced its plan to launch a test version of its Buildablock Website and mobile…
Santo Mining Corp. (SANP) Appoints Alain French as President and CEO
Santo Mining announced today that it has appointed Alain French as its President and CEO. Mr. French had previously been…
Valor Gold Corp. (VGLD) is “One to Watch”
Valor Gold is a junior exploration company currently focused on two key positions in North-Central Nevada's thriving mining industry (represents…
Cover-All Technologies, Inc. (COVR) Gets $2.25 Million Credit Facility from Imperium Partners to Fund Growth and Expansion
Cover-All Technologies said today that the Imperium Commercial Finance Master Fund LP, an affiliate of Imperium Partners, has agreed to…
GlobalWise Investments, Inc. (GWIV) Business Strategy Based On a Marriage of Technologies
When GlobalWise Investments recently announced that it had entered into a new Channel Sales Partnership arrangement with major independent office…
Valley High Mining Co. (VHMC) Signs Machacala Joint Venture Agreement
Valley High Mining is a precious metals exploration and development company. Its focus is on lower risk precious metal opportunities…
Dynegy Inc. (DYNIQ) Video Chart for Friday, September 14, 2012
DYNIQ has been holding a new support level at 40 cents since the beginning of August. Yesterday, there was a…
Cytori Therapeutics, Inc. (CYTX) Announces Japanese Cell Therapy Study for Peripheral Artery Disease
Cytori Therapeutics is a company developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to cardiovascular disease and repair…